Article
Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
The Journal of pathology - 1 May 2003
Pinto Mafalda, Oliveira Carla, Cirnes Luis, Carlos Machado José, Ramires Maria, Nogueira Ana, Carneiro Fátima, Seruca Raquel
Abstract excerpt
Transforming growth factor beta (TGFbeta) is a potent inhibitor of cell growth, whose action is transduced through interaction between type I (RI) and type II (RII) receptors. Abnormal expression of these receptors has been identified in several human cancers and was found to be associated with resistance to TGFbeta. TGFbeta RII mutations occur in many types of malignancy. TGFbeta RI hypermethylation has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
